These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20040018)

  • 1. Clinical significance of TC21 overexpression in oral cancer.
    Macha MA; Matta A; Sriram U; Thakkar A; Shukla NK; Datta Gupta S; Ralhan R
    J Oral Pathol Med; 2010 Jul; 39(6):477-85. PubMed ID: 20040018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of differentially expressed genes in oral squamous cell carcinoma.
    Arora S; Matta A; Shukla NK; Deo SV; Ralhan R
    Mol Carcinog; 2005 Feb; 42(2):97-108. PubMed ID: 15599930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
    Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
    Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TC21/R-Ras2 upregulation in esophageal tumorigenesis: potential diagnostic implications.
    Sharma R; Sud N; Chattopadhyay TK; Ralhan R
    Oncology; 2005; 69(1):10-8. PubMed ID: 16088230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry.
    Matta A; DeSouza LV; Shukla NK; Gupta SD; Ralhan R; Siu KW
    J Proteome Res; 2008 May; 7(5):2078-87. PubMed ID: 18407684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MGMT expression in oral precancerous and cancerous lesions: correlation with progression, nodal metastasis and poor prognosis.
    Sawhney M; Rohatgi N; Kaur J; Gupta SD; Deo SV; Shukla NK; Ralhan R
    Oral Oncol; 2007 May; 43(5):515-22. PubMed ID: 16996781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of nuclear pSTAT3 in oral cancer.
    Macha MA; Matta A; Kaur J; Chauhan SS; Thakar A; Shukla NK; Gupta SD; Ralhan R
    Head Neck; 2011 Apr; 33(4):482-9. PubMed ID: 20652980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas.
    Shintani S; Yoshihama Y; Emilio AR; Matsumura T
    Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias.
    Nasser W; Flechtenmacher C; Holzinger D; Hofele C; Bosch FX
    J Oral Pathol Med; 2011 Sep; 40(8):629-35. PubMed ID: 21435003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
    Ogmundsdóttir HM; Björnsson J; Holbrook WP
    J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronan-mediated motility: a target in oral squamous cell carcinoma.
    Yamano Y; Uzawa K; Shinozuka K; Fushimi K; Ishigami T; Nomura H; Ogawara K; Shiiba M; Yokoe H; Tanzawa H
    Int J Oncol; 2008 May; 32(5):1001-9. PubMed ID: 18425326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
    Arora S; Kaur J; Sharma C; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
    Clin Cancer Res; 2005 Mar; 11(6):2272-84. PubMed ID: 15788677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer.
    Kumar M; Matta A; Masui O; Srivastava G; Kaur J; Thakar A; Shukla NK; RoyChoudhury A; Sharma M; Walfish PG; Michael Siu KW; Chauhan SS; Ralhan R
    J Transl Med; 2015 Aug; 13():285. PubMed ID: 26318153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression signatures that can discriminate oral leukoplakia subtypes and squamous cell carcinoma.
    Kondoh N; Ohkura S; Arai M; Hada A; Ishikawa T; Yamazaki Y; Shindoh M; Takahashi M; Kitagawa Y; Matsubara O; Yamamoto M
    Oral Oncol; 2007 May; 43(5):455-62. PubMed ID: 16979924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan.
    Lin CY; Hung HC; Kuo RC; Chiang CP; Kuo MY
    Oral Oncol; 2005 Jul; 41(6):645-54. PubMed ID: 15927524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
    Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
    J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network-based analysis of calcium-binding protein genes identifies Grp94 as a target in human oral carcinogenesis.
    Nomura H; Uzawa K; Yamano Y; Fushimi K; Ishigami T; Kato Y; Saito K; Nakashima D; Higo M; Kouzu Y; Ono K; Ogawara K; Shiiba M; Bukawa H; Yokoe H; Tanzawa H
    Br J Cancer; 2007 Sep; 97(6):792-801. PubMed ID: 17726464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Lin PY; Yu CH; Wang JT; Chen HH; Cheng SJ; Kuo MY; Chiang CP
    J Oral Pathol Med; 2008 Jan; 37(1):18-25. PubMed ID: 18154573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Greater expression of TC21/R-ras2 in highly aggressive malignant skin cancer.
    Lee JH; Pyon JK; Lee SH; Lee YJ; Kang SG; Kim CH; Kim DW; Nam HS; Park YH; Jeong DJ; Cho MK
    Int J Dermatol; 2011 Aug; 50(8):956-60. PubMed ID: 21781067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.